Two Investigational Treatments for ALS Show Glimmer of Hope

[ad_1]

(MedPage Today) — The first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase II studies, but two treatments — pridopidine and CNM-Au8 — showed glimmers of hope.
All treatments…

[ad_2]

Source link : https://www.medpagetoday.com/neurology/generalneurology/114246

Author :

Publish date : 2025-02-17 16:01:00

Copyright for syndicated content belongs to the linked Source.